Associated Papers
Attenuation and efficacy of human parainfluenza virus type 1 (HPIV1) vaccine candidates containing stabilized mutations in the P/C and L genes.
Bartlett EJ et al.
Virology Journal, 2007
Introducing point and deletion mutations into the P/C gene of human parainfluenza virus type 1 (HPIV1) by reverse genetics generates attenuated and efficacious vaccine candidates.
Bartlett EJ et al.
Vaccine, 2006
Select a paper to view details